Blogs about ENZN - Stockpickr! Your Source for Stock Ideas

Blogs about ENZN

Blogs	Description	Date Updated
Enzon (ENZN) Holder DellaCamera Capital Wants Banker Hired To Explore Sale of Commercial Operations	In an amended 13D filing on Enzon Pharmaceuticals Inc. (Nasdaq: ENZN) this morning, 5.9% holder DellaCamera Capital disclosed a letter to the company saying while they are encouraged by the recently announced plan to spin-off its biotechnology business, the company must take the next logical step and explore all strategic alternatives for the Company's remaining commercial operations, including the sale of the commercial operations as a whole. DellaCamera demanded Enzon formally engage its advis...	May 20, 2008
Icahn eyes Enzon (ENZN): Activist targets biotech	Filed under: Newsletters, Stocks to Buy"Carl Icahn - one of Wall Street's most renowned and successful investors - is on another mission; this pitbull is sinking his teeth into one of the companies in our portfolio - Enzon Pharmaceuticals (NASDAQ: ENZN)," notes Marc Lichtenfeld. In Xcelerated Profits Report, the senior analyst and noted healthcare sector expert takes a look at the small cap biotechnology, which is involved in developing products for the treatment of cancer. "With an infamous r...	March 31, 2008
Icahn Files 13D on Enzon Pharma	Carl Icahn filed a 13D regarding his stake in Enzon Pharmaceuticals (ENZN) today. Icahn now may be deemed to beneficially own, in the aggregate, 3,072,103 Shares, representing approximately 6.93% of Enzon's outstanding Shares (based upon the 44,322,923 SharesAlso,"The Reporting Persons have entered into a number of derivative agreements, commonly known as Total Return Swaps, with counterparties, which agreements provide that the profit to the Reporting Persons shall be based upon the increase in...	March 14, 2008
Icahn Takes Larger Stake in Enzon (ENZN, IEP)	In an SEC Filing, it was disclosed that Carl Icahn has taken a larger stake as an activist in Enzon Pharmaceuticals Inc. (NASDAQ: ENZN). The stake is listed as... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	March 14, 2008
Carl Icahn Boosts Stake in Enzon Pharm (ENZN), Wants Co To Consider a Sale	In a 13D filing on Enzon Pharmaceuticals (Nasdaq: ENZN), Carl C. Icahn discloses a 6.93% stake (3,072,103 shares) in the company up from the 1,760,001 share stake held at the quarter ended 12/31/07. Icahn wants the company consider a sale.From the filing, "The Reporting Persons have had conversations with members of the Issuer’s management during which the Reporting Persons expressed their concern with the current Share price. In addition, during these conversations, the Reporting Persons indi...	March 14, 2008
Large Enzon (ENZN) Holder DellaCamera Capital Wants Company To Unlock Value	In a 13D filing on Enzon Pharmaceuticals Inc. (Nasdaq: ENZN), DellaCamera Capital disclosed a 5.2% stake (2,278,339 shares) in the company. The firm disclosed a letter to the company saying there is a troubling value disconnect in the stock. The firm requested the company hire an advisor to analyze various financial and structural options and implement a cohesive financial plan of action that would deliver increased value to the shareholders.The firm said these options may include the rationaliz...	December 19, 2007
What's Next For Icahn Following His BEAS and BIIB Windfall?	Given activist investor Carl Icahn's recent "golden touch", in light of last week's BEA Systems (Nasdaq: BEAS) buyout offer and the Biogen (Nasdaq: BIIB) sale news, we took a close look at Icahn's portfolio to see if there are any other potential companies that could be activist/takeover targets. Two companies from Icahn's portfolio that grabbed our interest were Enzon Pharmaceuticals Inc. (Nasdaq: ENZN) and Global Payments Inc. (NYSE: GPN).Icahn initiated a 1,740,001 share stake in Enzon (3.95%...	October 15, 2007

Enter search text here: